Drug · DIN 02455366
TADALAFIL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 9, 2016; first marketed September 9, 2016.
- Drug Identification Number (DIN)
- 02455366
- Company (DIN owner)
- Pro Doc LimiteeLaval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tadalafil G04BE08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TADALAFIL | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 22, 2016: NOC 18297Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named TADALAFIL
- DIN 02455358 · Marketed
- DIN 02455374 · Marketed
- DIN 02457016 · Marketed
- DIN 02457024 · Marketed
- DIN 02457032 · Marketed
- DIN 02536676 · Marketed
- DIN 02536684 · Marketed
- DIN 02536692 · Marketed
- DIN 02536706 · Marketed
- DIN 02441098 · Approved
- DIN 02441101 · Approved
- DIN 02441128 · Approved
- DIN 02441136 · Approved